Načítá se...
Survivin is a prognostic marker and therapeutic target for extranodal, nasal-type natural killer/T cell lymphoma
BACKGROUND: The relationship between survivin and extranodal, nasal-type natural killer/T cell lymphoma (ENKTCL) was unclearly established yet. We here studied the potential prognostic roles of survivin and its implication as a target in ENKTCL therapy. METHODS: ENKTCL patients’ peripheral blood wer...
Uloženo v:
| Vydáno v: | Ann Transl Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AME Publishing Company
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6694227/ https://ncbi.nlm.nih.gov/pubmed/31475186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.06.53 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|